表紙
市場調查報告書

腫瘤生物相似藥的全球市場分析 (2020∼30年)

Oncology Biosimilars Market Global Report 2020-30

出版商 The Business Research Company 商品編碼 931982
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
腫瘤生物相似藥的全球市場分析 (2020∼30年) Oncology Biosimilars Market Global Report 2020-30
出版日期: 2020年04月10日內容資訊: 英文
簡介

本報告提供全球腫瘤生物相似藥的市場結構、趨勢相關分析,市場的主要特徵、結構,及整體市場規模、成長率趨勢預測 (2015∼2019年,2023年,2025年,2030年),藥物的各類型、癌症的各類型、各流通管道及各地區、主要國家詳細趨勢,與主要的宏觀經濟指標的對比,主要企業的簡介,近幾年的主要趨勢等調查。

為本報告提供以下的疑問回答。

  • 癌症治療用生物相似藥最大且快速成長的市場在哪裡?
  • 生物相似藥市場與整體經濟,人口統計數據和其他類似市場之間的關係如何?
  • 哪些動態將在未來塑造市場?

目錄

第1章 摘要整理

第2章 腫瘤生物相似藥市場特徵

第3章 腫瘤生物相似藥市場:市場規模、成長率

  • 市場規模 (以金額為準,2015∼2019年)
  • 市場規模 (以金額為準,2019∼2023年,2025年,2030年)
    • 推動市場要素
    • 阻礙市場要素

第4章 腫瘤生物相似藥市場:各領域分析

  • 藥物的各種類的市場規模 (以金額為準,成果值、預測值)
    • 單株抗體
    • 免疫調節劑
    • 造血劑
    • 顆粒細胞增生因子 (G-CSF)
  • 癌症的各種類的市場規模 (以金額為準,成果值、預測值)
    • 乳癌
    • 大腸癌症
    • 血液癌症
    • 嗜中性白血球低下症
    • 非小細胞肺癌
    • 其他
  • 流通管道的各種類的市場規模 (以金額為準,成果值、預測值)
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第5章 腫瘤生物相似藥市場:各地區、各國分析

  • 各地區的市場規模 (以金額為準,成果值、預測值)
  • 各國市場規模 (以金額為準,成果值、預測值)

第6章 亞太地區的腫瘤生物相似藥市場

  • 市場概要
  • 藥物的各種類的市場規模 (以金額為準,成果值、預測值)

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐的腫瘤生物相似藥市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐的腫瘤生物相似藥市場

第18章 俄羅斯市場

第19章 北美的腫瘤生物相似藥市場

第20章 美國市場

第21章 南美的腫瘤生物相似藥市場

第22章 巴西市場

第23章 中東的腫瘤生物相似藥市場

第24章 非洲的腫瘤生物相似藥市場

第25章 腫瘤生物相似藥市場:競爭環境和企業簡介

  • 競爭環境
  • 企業簡介
    • Biocoin
    • Celltrion Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Intas Pharmaceuticals Ltd.
    • STADA Arzneimittel AG

第26章 腫瘤生物相似藥市場上主要企業合併、收購 (M&A)

第27章 腫瘤生物相似藥市場趨勢與策略

第28章 腫瘤生物相似藥市場:未來展望與潛在力分析

第29章 附錄

目錄

‘Oncology Biosimilars Market Global Report 2020-30 ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology biosimilars market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology biosimilars? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? ‘The Oncology Biosimilars market global report ’ from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The oncology biosimilars market section of the report gives context. It compares the oncology biosimilars market with other segments of the oncology biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology biosimilars indicators comparison.

Scope:

Markets Covered: 1) By Drug Type: Monoclonal Antibody; Immunomodulators; Hematopoietic Agents; Granulocyte Colony-Stimulating Factor (G-CSF)

2) By Cancer Type: Breast Cancer; Colorectal Cancer; Blood Cancer; Neutropenia Cancer; Non-Small Cell Lung Cancer; Others

3) By Distribution Type: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Companies Mentioned: Biocoin; Celltrion Inc.; Dr. Reddy's Laboratories Ltd.; Intas Pharmaceuticals Ltd.; STADA Arzneimittel AG

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oncology Biosimilars Market Characteristics

3. Oncology Biosimilars Market Size And Growth

  • 3.1. Global Oncology Biosimilars Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Oncology Biosimilars Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Oncology Biosimilars Market Segmentation

  • 4.1. Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Monoclonal Antibody

Immunomodulators

Hematopoietic Agents

Granulocyte Colony-Stimulating Factor (G-CSF)

  • 4.2. Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Breast Cancer

Colorectal Cancer

Blood Cancer

Neutropenia Cancer

Non-Small Cell Lung Cancer

Others

  • 4.3. Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

5. Oncology Biosimilars Market Regional And Country Analysis

  • 5.1. Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Oncology Biosimilars Market

  • 6.1. Asia-Pacific Oncology Biosimilars Market Overview
  • 6.2. Asia-Pacific Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Oncology Biosimilars Market

  • 7.1. China Oncology Biosimilars Market Overview
  • 7.2. China Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Oncology Biosimilars Market

  • 8.1. India Oncology Biosimilars Market Overview
  • 8.2. India Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Oncology Biosimilars Market

  • 9.1. Japan Oncology Biosimilars Market Overview
  • 9.2. Japan Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Oncology Biosimilars Market

  • 10.1. Australia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Oncology Biosimilars Market

  • 11.1. Indonesia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Oncology Biosimilars Market

  • 12.1. South Korea Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Oncology Biosimilars Market

  • 13.1. Western Europe Oncology Biosimilars Market Overview
  • 13.2. Western Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Oncology Biosimilars Market

  • 14.1. UK Oncology Biosimilars Market Overview
  • 14.2. UK Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Oncology Biosimilars Market

  • 15.1. Germany Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Oncology Biosimilars Market

  • 16.3. France Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Oncology Biosimilars Market

  • 17.1. Eastern Europe Oncology Biosimilars Market Overview
  • 17.2. Eastern Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Oncology Biosimilars Market

  • 18.1. Russia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Oncology Biosimilars Market

  • 19.1. North America Oncology Biosimilars Market Overview
  • 19.2. North America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Oncology Biosimilars Market

  • 20.1. USA Oncology Biosimilars Market Overview
  • 20.2. USA Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Oncology Biosimilars Market

  • 21.1. South America Oncology Biosimilars Market Overview
  • 21.2. South America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Oncology Biosimilars Market

  • 22.1. Brazil Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Oncology Biosimilars Market

  • 23.1. Middle East Oncology Biosimilars Market Overview
  • 23.2. Middle East Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Oncology Biosimilars Market

  • 24.1. Africa Oncology Biosimilars Market Overview
  • 24.2. Africa Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Oncology Biosimilars Market Competitive Landscape And Company Profiles

  • 25.1. Oncology Biosimilars Market Competitive Landscape
  • 25.2. Oncology Biosimilars Market Company Profiles
    • 25.2.1. Biocoin
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Celltrion Inc.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Dr. Reddy's Laboratories Ltd.
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Intas Pharmaceuticals Ltd.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. STADA Arzneimittel AG
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Oncology Biosimilars Market

27. Oncology Biosimilars Market Trends And Strategies

28. Oncology Biosimilars Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer